USPTO serial 79281530
THERAPANACEA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 25, 2022
- Examiner
- VALLILLO, MELISSA C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with THERAPANACEA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jess M. Collen
Jess M. Collen Collen IP Intellectual Property Law, P.C.80 South Highland AvenueTHE HOLYOKE-MANHATTAN BUILDINGOssining, NY 10562Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | image recording apparatus; image transmission apparatus; image reproduction apparatus; digital recording media, namely, video recorders; diagnostic apparatus not for medical use, namely, apparatus for the detection of pathogens for laboratory or research use; downloadable software for use in the field of cancer therapy and pathogen detection; recorded software for use in determining treatment protocols in the field of cancer therapy; downloadable artificial intelligence software in particular for use in determining treatment protocols in relation to precision radiotherapy treatment of cancer; downloadable software applications for use in medical data analysis; downloadable software platforms for use in analysis of medical outcomes; recorded or downloadable embedded operating software for X-ray CT scanners; downloadable tablet computer software and software applications for use in medical data analysis; recorded virtual reality software for use in guiding surgical instruments during surgery; data storage devices for use in the field of cancer management; teaching apparatus and simulators, namely, electronic clinicians training simulators | ACTIVE | — |
| 038 | provision of access to databases; transmission of medical digital files; transmission of digital files for use in the reception, care and accompaniment of sick persons and of patients through computer applications and dynamic display screens, a website accessible online particularly via a tablet, mobile telephone or computer, via a social network and via interactive orientation terminals; all the foregoing in the field of cancer research and cancer treatment | ACTIVE | — |
| 042 | Scientific and medical research; research and development of new therapies for cancer treatment; scientific research in the medical field, in particular relating to cancer treatment; software design using artificial intelligence in the field of cancer treatment aimed at developing precision radiation therapy for improving the clinical effects of treatment; computer system analysis; computer system design; computer hardware design and development services provided by consultants; digitization of documents; software as a service (SaaS) services featuring software for use in analyzing medical research data; cloud computing featuring software for use in scientific data management; information technology (IT) consultancy; server hosting; electronic data storage; all the foregoing in the medical field, in particular for cancer treatment | ACTIVE | — |
| 044 | medical analysis services, namely, medical diagnostic testing services; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; laboratory services relating to treatment of persons, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical imaging, radiotherapy, brachytherapy and medical dosimetry services for the treatment of cancer; information in the field of cancer treatment; medical services for cancer treatment; medical analysis services for cancer diagnosis; providing cancer screening services; information in the fields of health, cancer and cancer treatment, recovery and survival via a global computer network; medical evaluation and medical diagnosis of cancer; prognosis evaluation in cancer therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by THERAPANACEA
- Other trademarks owned by THERAPANACEA
- Other trademarks owned by THERAPANACEA
- Other trademarks in Class 009
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named THERAPANACEA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 4, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 29, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 18, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 29, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 29, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 25, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 19, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 20, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 20, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Sep 10, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 30, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 25, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 25, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 2, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 22, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 22, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 22, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 8, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 8, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 8, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 8, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 8, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 8, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 7, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 7, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 16, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 15, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 28, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 27, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 23, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |